Sector: Pharmaceuticals & Biotechnology

Mid Cap

Viyash Scientific Share Price

VIYASH

₹282

0.95(0.34%)

No Graph

NSE : VIYASH

Open Free Demat Account

Viyash Scientific Performance

Price Movement

N/A

₹274.15

₹283.00

↘ Today's Low↗ Today's High

1 Year Performance

N/A

₹166.00

₹298.00

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹283.00

Low₹274.15

Open at₹282.00

Prev Close₹281.05

Volumes16.18 L

Avg Price₹278.92

Lower Circuit₹224.85

Upper Circuit₹337.25

Historical Performance

3M High₹298.00

3M Low₹199.88

1 Yr High₹298.00

1 Yr Low₹166.00

3 Yr High₹298.00

3 Yr Low₹86.40

5 Yr High₹319.15

5 Yr Low₹61.80

Summary

As of 10-07-2026 20:02, Viyash Scientific Ltd. share price today is ₹0, with a change of ₹-281.05 (-100.00%) from the previous close of ₹281.05. The stock opened at ₹282 and traded between ₹274.15 and ₹283, with a total traded volume of 1617533 shares. The company has a market capitalization of ₹12278.4 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹298 and ₹166, respectively.

Viyash Scientific Ltd. valuation metrics include a P/E ratio of 102.7, EPS of ₹4.09, and book value of ₹4.20. Profitability indicators show ROE of 6.08%. Viyash Scientific Ltd. has reported revenue of ₹2643.78 Cr and net profit of ₹119.6 Cr.

Viyash Scientific Ltd. technical indicators include Day RSI at 59.6, Day MFI at 81.25, Day ADX at 50.96. Additional indicators include Commodity Channel Index (CCI) at 53.7 and Williams %R at -37.67. Momentum indicators show Day MACD at 10.26, Day MACD Signal Line at 10.68, DayATR at 12.47. Rate of Change indicators for Viyash Scientific Ltd. include ROC125 at 33.52 and ROC21 at 9.19.

Exponential moving averages include EMA5 at ₹280.2, EMA10 at ₹278.4, EMA12 at ₹277.1, EMA20 at ₹271.1, EMA26 at ₹266.8, EMA50 at ₹252.6, EMA100 at ₹235.9, EMA200 at ₹219.4. Simple moving averages include SMA5 at ₹282.9, SMA10 at ₹281.1, SMA20 at ₹268.4, SMA30 at ₹263.2, SMA50 at ₹248.4, SMA100 at ₹226.2, SMA150 at ₹219.6, SMA200 at ₹217.8.

Support levels for Viyash Scientific are placed at First Support ₹274.40, Second Support ₹267.75, Third Support ₹262.95. Resistance levels are seen at First Resistance ₹285.85, Second Resistance ₹290.65, Third Resistance ₹297.30. Viyash Scientific Ltd. shareholding pattern shows promoter holding at 61.31%, FII holding at 2.94%, DII holding at 0%, public holding at 27.67%.

Viyash Scientific Fundamentals

Market Cap

High in industry

12,278.40 Cr.

PE Ratio (TTM)

High in industry

102.70

Dividend Yield

Net Profit TTM

317.4% incr over last year

119.60

Net Profit Growth

317.4% incr over last year

119.60

PEG Ratio

Above industry Median

0.30

ROE

96.1% incr over last year

6.08

Operating Revenue TTM

2,643.78

Operating Revenue Growth

70.4% incr over last year

Book Value

Above industry Median

4.20

MFI

MFI strongly Overbought

81.25

RSI

RSI is mid-range

59.60

EPS (TTM)

4.09

Debt to Equity

0.15

Face Value

Operating Profit Margin Qtr.

18.84

Operating Profit Qtr.

184.25

Net Profit Qtr.

52.11

Operating Revenue Qtr.

919.96

PB Ratio

4.20

Viyash Scientific Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Revenue	372.49	341.64	34.03	41.07	42.33
Operating Expense	309.80	271.30	36.67	43.11	45.15
Operating Profit	62.69	70.34	-2.64	-2.04	-2.82
Depreciation	31.16	31.20	2.24	2.33	2.30
Interest	2.53	3.56	0.83	1.08	0.99
Tax	12.94	10.69	1.26	1.41	1.68
Net Profit	35.81	-0.08	3.08	3.37	4.23

Viyash Scientific Technicals

Viyash Scientific Ltd. EMA & SMA

₹274.55

3.95 (1.46%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹280.2

Day EMA10 ₹278.4

Day EMA12 ₹277.1

Day EMA20 ₹271.1

Day EMA26 ₹266.8

Day EMA50 ₹252.6

Day EMA100 ₹235.9

Day EMA200 ₹219.4

Viyash Scientific Support and Resistance

Resistance

First Resistance₹285.85

Second Resistance₹290.65

Third Resistance₹297.30

Support

First Support₹274.40

Second Support₹267.75

Third Support₹262.95

Technical Indicators

Day RSI59.60

Day MFI81.25

Day ADX50.96

Day Commodity Channel Index53.70

William-37.67

Day MACD10.26

Day MACD Signal Line10.68

Day ATR12.47

Day ROC12533.52

Day ROC219.19

Viyash Scientific Shareholding Pattern

Held By	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoter	52.6	52.6	52.6	52.3	61.4	61.3
FII	6.1	6	6.2	5.9	3.2	2.9
DII	12	12.9	12.9	12.9	7.3	8
Public	29.1	28.4	28.1	28.7	28	27.7

Viyash Scientific Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	7.88 L	15.01 L	52.48%
Week	9.06 L	17.95 L	50.48%
1 Month	14.22 L	27.58 L	51.57%
6 Month	8.16 L	16.95 L	48.14%

Viyash Scientific SWOT Analysis

Strengths29

Weakness6

Opportunity2

Threats0

Benjamin Graham Value Screen

Strong Performer, Getting Expensive (DVM)

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Companies with 10% increase in share price over three months, with rising net profit growth

Strong Momentum: Price above short, medium and long term moving averages

Relative Outperformance versus Industry over 1 Month

Rising Net Cash Flow and Cash from Operating activity

Companies with high TTM EPS Growth

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Month

Overbought by Money Flow Index (MFI)

Effectively using its capital to generate profit - RoCE improving in last 2 years

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Growth in Net Profit with increasing Profit Margin (QoQ)

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Companies with Low Debt

Increasing profits every quarter for the past 4 quarters

Increasing Revenue every quarter for the past 2 quarters

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Annual Net Profits improving for last 2 years

Companies with Zero Promoter Pledge

Near 52 Week High

RSI indicating price strength

Top Gainers

Stocks near 52 Week High with Significant Volumes

Stocks Outperforming their Industry Price Change in the Quarter

Viyash Scientific Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
08 Sep, 2021	0.5	FINAL	10 Sep, 2021	Equity Share
21 Aug, 2019	0.2	FINAL		Equity Share
20 Nov, 2017	0.2	INTERIM	21 Nov, 2017	Equity Share
16 Sep, 2011	1.5	FINAL		Equity Share
23 Sep, 2010	2	FINAL		Equity Share
02 Sep, 2009	1	FINAL		Equity Share
11 Sep, 2008	1	FINAL		Equity Share
13 Sep, 2007	1	FINAL		Equity Share

Viyash Scientific Stock Comparison

Financials	Corona Remedies Ltd.	Sudeep Pharma Ltd.	Senores Pharmaceuticals Ltd.	OneSource Specialty Pharma Ltd.	Sanofi Consumer Healthcare India Ltd.	Akums Drugs & Pharmaceuticals Ltd.
Price (₹)	₹2,044	₹825	₹1,410.10	₹1,625.50	₹4,565	₹704.20
% Change	1.05%	2.83%	-0.68%	-0.01%	1.30%	6.99%
Revenue TTM (₹ Cr)	₹1,403.18	₹642.26	₹649.50	₹1,421.59	₹935	₹4,359.02
Net Profit TTM (₹ Cr)	₹185.12	₹172.89	₹115.38	₹-73.80	₹257.90	₹255.19
PE TTM	66.80	52.40	56.70	-252.60	40.20	40.60
1 Year Return	90.47	35.3	141.77	-19.54	-13.64	17.17
ROCE	31.54	24.22	15.60	0.59	-	11.40

Similar Stocks

INNOVACAP

Innova Captab Ltd.

₹ 990.00

-0.09%

BLUEJET

Blue Jet Healthcare Ltd

₹ 622.50

+8.36%

CONCORDBIO

Concord Biotech Ltd.

₹ 1304.50

-0.07%

AARTIPHARM

Aarti Pharmalabs Ltd.

₹ 709.35

+0.91%

SUPRIYA

Supriya Lifescience Ltd.

₹ 856.00

-2.16%

ALIVUS

Alivus Life Sciences Ltd.

₹ 1159.90

+1.49%

COHANCE

Cohance Lifesciences Ltd.

₹ 452.00

+2.69%

ERIS

Eris Lifesciences Ltd.

₹ 1426.20

-0.27%

SYNGENE

Syngene International Ltd.

₹ 422.40

+1.69%

APLLTD

Alembic Pharmaceuticals Ltd.

₹ 838.00

+2.58%

SPARC

Sun Pharma Advanced Research Company Ltd.

₹ 265.00

-4.53%

STAR

Strides Pharma Science Ltd.

₹ 1083.00

+0.65%

FDC

FDC Ltd.

₹ 432.60

+0.12%

SHILPAMED

Shilpa Medicare Ltd.

₹ 626.90

+0.74%

JUBLPHARMA

Jubilant Pharmova Ltd.

₹ 969.00

-0.02%

NATCOPHARM

Natco Pharma Ltd.

₹ 983.70

+2.30%

CAPLIPOINT

Caplin Point Laboratories Ltd.

₹ 2599.90

-0.82%

MARKSANS

Marksans Pharma Ltd.

₹ 270.50

-2.45%

ORCHPHARMA

Orchid Pharma Ltd.

₹ 1008.00

-4.09%

BLISSGVS

Bliss GVS Pharma Ltd.

₹ 522.40

-0.33%

SANOFI

Sanofi India Ltd.

₹ 3415.00

+1.76%

PGHL

Procter & Gamble Health Ltd.

₹ 6800.00

+2.84%

JSLL

Jeena Sikho Lifecare Ltd.

₹ 591.00

-0.10%

FAQ's on VIYASH

What is the Market Capitalization of Viyash Scientific Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Viyash Scientific Ltd. is approximately ₹ 12278.4 Cr.

What are the PE and PB ratios for Viyash Scientific Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Viyash Scientific Ltd. is 102.7, and the Price-to-Book (PB) ratio is 4.2.

What is the 52-Week High and Low for Viyash Scientific Ltd.?

Over the past 52 weeks, the highest price reached by Viyash Scientific Ltd. shares was ₹ 298, and the lowest price was ₹ 166.

Who are the major shareholders of Viyash Scientific Ltd.?

Significant shareholdings in Viyash Scientific Ltd. typically include entities such as:

Promoter
Public
Mutual Funds
FII
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Viyash Scientific Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Viyash Scientific Ltd. is often compared with other major players such as Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda and Rekvina Laboratories for analysis and benchmarking.

What is the latest dividend information for Viyash Scientific Ltd.?

Viyash Scientific Ltd. last declared a FINAL dividend of ₹ 0.5 per share for the financial period ending 2021. The record date was set as 2021-09-08, and the payment was/is scheduled around 2021-09-08. For the most current dividend announcements, refer to official company filings.